434

Compound name
Cobimetinib
Alt Name
GDC-0973
XL518
Cotellic
Compound Image
Cobimetinib.png
SMILES
C1CCN[C@@H](C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O
MW
531.30
Brutto
C21H21F3IN3O2
InChI
InChI=1S/C21H21F3IN3O2/c22-14-6-5-13(19(18(14)24)27-16-7-4-12(25)9-15(16)23)20(29)28-10-21(30,11-28)17-3-1-2-8-26-17/h4-7,9,17,26-27,30H,1-3,8,10-11H2/t17-/m0/s1
InChI Key
BSMCAPRUBJMWDF-KRWDZBQOSA-N
Approval Jurisdiction
2015 FDA 2015 EMA
Approved for clinical use
Melanoma, Breast Cancer
CAS
934660-93-2
PubChem CID
16222096
Action
MEK1/2
Approved Drug List
1
Commercial Vendor
Roche Exelixis